Skip to main content
. 2022 Jun 6;10(16):5470–5478. doi: 10.12998/wjcc.v10.i16.5470

Table 1.

Comparisons of bladder metastasis from hepatocellular carcinoma based on previous case reports

Case report
Location Sex Age (yr) HCC Etiology Previous treatment Other metastasis site Comorbidity Liver biopsy Bladder biopsy Treatment Prognosis
Current case Rep. of Korea F 60 HBV TACE #2 None None O O TUR-BT, systemic CTx Under follow up
Kurimoto et al[13], 1993 Japan M 74 Unknown None Chest wall History of stomach bleeding X O TUR-BT Died 6 months later
Franks et al[14], 1999 USA M 51 HCV, Alcoholic LC LT, Adjuvant CTx Lung None X O TUR-BT, systemic CTx Unknown
Al-Brahim et al[15], 2004 Canada M 83 Unknown None Left adrenal gland? Synchronous transitional cell carcinoma X O Unknown Unknown
Chung et al[12], 2007 Taiwan F 58 C-viral LC None Unknown Cervical cancer, Hemorrhagic cystitis after RTx X O TUR-BT Died 5 months later
Yasutomi et al[16], 2020 Japan M 89 Alcoholic LC TACE None None X O TUR-BT Unknown

HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; TACE: Transcatheter arterial chemoembolization; TUR-BT: Transurethral resection of bladder tumor; CTx: Chemotherapy; HCV: Hepatitis C virus; LC: Liver cirrhosis; LT: Liver transplantation; RTx: Radiotherapy.